Letter by Kim et al Regarding Article, "Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial"

Yongcheol Kim^{1

2}, Thomas W Johnson³, Myung Ho Jeong²

Affiliations

¹ Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine and Cardiovascular Center, Yongin Severance Hospital, Korea (Y.K.).
² Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea (Y.K., M.H.J.).
³ Department of Cardiology, Bristol Heart Institute, United Kingdom (T.W.J.).

Comment

Yongcheol Kim et al. Circulation. 2020.

. 2020 Apr 7;141(14):e737-e738.

doi: 10.1161/CIRCULATIONAHA.119.044256. Epub 2020 Apr 6.

Yongcheol Kim^{1

2}, Thomas W Johnson³, Myung Ho Jeong²

¹ Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine and Cardiovascular Center, Yongin Severance Hospital, Korea (Y.K.).
² Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea (Y.K., M.H.J.).
³ Department of Cardiology, Bristol Heart Institute, United Kingdom (T.W.J.).

No abstract available

Comment in

Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial.
Park DW, Kwon O, Jang JS, Yun SC, Park H, Kang DY, Ahn JM, Lee PH, Lee SW, Park SW, Choi SW, Lee SG, Yoon HJ, Ahn T, Kim MH, Nah DY, Lee SY, Chae JK, Park SJ; TICAKOREA Investigators. Park DW, et al. Circulation. 2019 Dec 3;140(23):1865-1877. doi: 10.1161/CIRCULATIONAHA.119.041766. Epub 2019 Sep 25. Circulation. 2019. PMID: 31553203 Clinical Trial.